7. Accrued Expenses
Accrued expenses consisted of the following as of September 30, 2018 and December 31, 2017 (in thousands):
September 30, 2018
December 31, 2017
External research and preclinical development
$
7,910
5,875
Employee compensation and benefits
2,461
2,494
Professional fees
695
1,225
Facilities and other
93
134
11,159
9,728
The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.
No definition available.